Latest News for: ea korea

Edit

Newron presents 2024 financial results and provides 2025 outlook

Pharmiweb 01 Apr 2025
Newron has signed development and commercialization agreements for evenamide with EA Pharma (a subsidiary of Eisai) for Japan and other Asian territories, as well as Myung In Pharm for South Korea.
Edit

Newron proposes renowned biopharma company founder and entrepreneur Dr. Chris Martin for election as Independent Chairman

Pharmiweb 24 Mar 2025
EQS-News. Newron Pharmaceuticals S.p.A. / Key word(s) ... Newron has signed development and commercialization agreements for evenamide with EA Pharma (a subsidiary of Eisai) for Japan and other Asian territories, as well as Myung In Pharm for South Korea ... .
  • 1
×